Peripheral Drug Eluting Balloons Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Afri

Peripheral Drug Eluting Balloons Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global market for peripheral drug eluting balloons (DEBs) is poised for remarkable growth, according to a recent study by Fairfield Market Research. Over the past decade, the market has expanded at a commendable Compound Annual Growth Rate (CAGR) of 6%, reaching a valuation of US$ 880 million in 2024. Projections suggest a significant surge ahead, with an anticipated CAGR of 10.0% by the end of 2031, propelling the market to a valuation of US$ 1700 million.

Peripheral DEBs are critical medical devices used in interventional cardiology and other medical fields to address various cardiovascular conditions, particularly arterial blockages or stenosis. These devices combine mechanical balloon angioplasty with localized medication delivery, offering a comprehensive treatment approach.

Rising Aging Population and Increasing Prevalence of Vascular Diseases Driving Market Growth

One of the primary factors fueling the rapid expansion of the peripheral DEBs market is the global aging population and the consequent increase in vascular diseases. The geriatric demographic is particularly susceptible to vascular ailments, contributing to a heightened demand for peripheral vascular surgeries. Furthermore, with improved life expectancies and an expected rise in the global elderly population, opportunities for manufacturers are burgeoning. The World Health Organization estimates a staggering increase in the elderly population, from 900 million in 2015 to 2 billion by 2050.

Challenges Faced by Market Players

Despite the promising growth trajectory, market players encounter challenges, including high product costs and limited clinical evidence. The upfront expenses associated with DEBs, along with the need for robust long-term clinical data, pose obstacles to widespread adoption, especially in regions with constrained healthcare budgets or reimbursement constraints. Addressing these challenges is crucial for sustained market expansion and accessibility.

Country-wise Insights: United States, China, and Germany

In the United States, the market for peripheral DEBs is set to witness significant growth due to the rising prevalence of peripheral artery disease (PAD) and advancements in product development. Similarly, China presents lucrative opportunities driven by favorable government policies, healthcare reforms, and reimbursement support. Collaborations between local and international entities facilitate technology transfer and market expansion.

Germany, renowned for its advanced healthcare infrastructure, provides a conducive environment for the adoption of innovative medical technologies like DEBs. Awareness campaigns and education initiatives about peripheral artery disease are contributing to greater product acceptance and adoption in the country.

Category-wise Insights: Paclitaxel Drug Coating and Peripheral Arterial Disease Indication

Paclitaxel drug coating emerges as a significant driver of market demand, accounting for a substantial share in 2023. Its efficacy in inhibiting neointimal hyperplasia and reducing restenosis risk underscores its importance in peripheral DEBs. Additionally, the prevalence of peripheral arterial disease remains a dominating factor, with common risk factors contributing to its increasing incidence globally.

Competition Analysis

The market for peripheral drug eluting balloons boasts a competitive landscape, with global and local businesses vying for market share. Efforts to expand presence in emerging markets and maintain distributor connections underscore the competitive environment.

Key Segments of Peripheral Drug Eluting Balloons Industry Research

Drug Coating:
• Paclitaxel Drug Coating
• Sirolimus drug Coating
• Others

Indication:
• Peripheral Arterial Disease
• Peripheral Aneurysms
• In-Stent Restenosis
• Others

Artery Type:
• Carotid Arteries
• Fem-Pop Arteries
• Iliac Arteries
• Infrapop Arteries

End User:
• Hospitals
• Ambulatory Surgical Centers/Outpatients
• Cardiac Catheterization Labs

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.